[go: up one dir, main page]

DK1788876T3 - Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf - Google Patents

Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf

Info

Publication number
DK1788876T3
DK1788876T3 DK05786030T DK05786030T DK1788876T3 DK 1788876 T3 DK1788876 T3 DK 1788876T3 DK 05786030 T DK05786030 T DK 05786030T DK 05786030 T DK05786030 T DK 05786030T DK 1788876 T3 DK1788876 T3 DK 1788876T3
Authority
DK
Denmark
Prior art keywords
pseudopolymorphs
salts
preparation
imidazole compounds
imidazole
Prior art date
Application number
DK05786030T
Other languages
English (en)
Inventor
Ines Petschen
Xavier Camps
Juan Sallares
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1788876(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1788876T3 publication Critical patent/DK1788876T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK05786030T 2004-09-13 2005-09-13 Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf DK1788876T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200402183A ES2249991B1 (es) 2004-09-13 2004-09-13 Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
PCT/EP2005/009825 WO2006029812A1 (en) 2004-09-13 2005-09-13 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof

Publications (1)

Publication Number Publication Date
DK1788876T3 true DK1788876T3 (da) 2009-08-31

Family

ID=35295386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05786030T DK1788876T3 (da) 2004-09-13 2005-09-13 Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf

Country Status (23)

Country Link
US (1) US7829726B2 (da)
EP (1) EP1788876B1 (da)
JP (1) JP4866355B2 (da)
KR (1) KR100861436B1 (da)
CN (1) CN100579966C (da)
AR (1) AR053093A1 (da)
AT (1) ATE431076T1 (da)
AU (1) AU2005284331B2 (da)
BR (1) BRPI0515254A (da)
CA (1) CA2577253C (da)
DE (1) DE602005014491D1 (da)
DK (1) DK1788876T3 (da)
ES (1) ES2249991B1 (da)
MX (1) MX2007002924A (da)
NO (1) NO337950B1 (da)
PA (1) PA8645401A1 (da)
PE (1) PE20060690A1 (da)
PL (1) PL1788876T3 (da)
PT (1) PT1788876E (da)
RU (1) RU2357965C2 (da)
TW (1) TWI357813B (da)
UY (1) UY29116A1 (da)
WO (1) WO2006029812A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012511539A (ja) * 2008-12-09 2012-05-24 フエルレル インターナショナル,ソシエダッド アノニマ 抗真菌化合物の多形体ii
US10437922B2 (en) * 2015-12-03 2019-10-08 Workday, Inc. Spreadsheet with unit based conversions
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
ES529608A0 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
ES2249991B1 (es) 2007-03-01
TW200618799A (en) 2006-06-16
CN100579966C (zh) 2010-01-13
PE20060690A1 (es) 2006-07-11
KR20070049663A (ko) 2007-05-11
HK1104765A1 (en) 2008-01-25
JP4866355B2 (ja) 2012-02-01
CA2577253C (en) 2012-11-20
NO20071818L (no) 2007-05-04
JP2008512422A (ja) 2008-04-24
EP1788876B1 (en) 2009-05-13
ATE431076T1 (de) 2009-05-15
US7829726B2 (en) 2010-11-09
PT1788876E (pt) 2009-08-17
CN101022727A (zh) 2007-08-22
DE602005014491D1 (de) 2009-06-25
TWI357813B (en) 2012-02-11
MX2007002924A (es) 2007-06-15
AU2005284331A1 (en) 2006-03-23
KR100861436B1 (ko) 2008-10-02
PA8645401A1 (es) 2006-06-02
EP1788876A1 (en) 2007-05-30
NO337950B1 (no) 2016-07-18
ES2249991A1 (es) 2006-04-01
RU2007113922A (ru) 2008-10-20
US20090005573A1 (en) 2009-01-01
AR053093A1 (es) 2007-04-25
BRPI0515254A (pt) 2008-07-15
UY29116A1 (es) 2005-11-30
PL1788876T3 (pl) 2009-11-30
RU2357965C2 (ru) 2009-06-10
CA2577253A1 (en) 2006-03-23
AU2005284331B2 (en) 2010-12-23
WO2006029812A1 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
IL284991A (en) Antibodies against cd38 for treatment of multiple myeloma
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1830850T3 (da) Quinolin-derivater til behandling af latent tuberkulose
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK2101819T3 (da) Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
DK2068874T3 (da) Fremgangsmåder til behandling af multiple myelom med anvendelse af kombinationsterapier baseret på anti-cs1 antistoffer
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK1781604T3 (da) Bis(thio-hydrazid-amid)-salte til behandling af cancere
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK2215050T3 (da) Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
FI20040011L (fi) Menetelmä pintojen käsittelemiseksi
DK2146742T3 (da) Cellelinjer, sammensætninger omfattende disse til behandling af melanomer, fremgangsmåder til at fremstille sammensætningerne og behandlingsmetoder
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
FI20041515A7 (fi) Menetelmä lääketieteellisten stenttien valmistamiseksi
DK2182007T3 (da) Fremgangsmåde til fremstilling af humant G-CSF
DK4070800T3 (da) Cladribinkur til behandling af multipel sklerose
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1788876T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser og salte og pseudopolymorfer deraf